Evaluation of serum HER2-ECD levels in patients with gastric cancer

Katsunobu Oyama,Sachio Fushida,Tomoya Tsukada,Jun Kinoshita,Toshifumi Watanabe,Masatoshi Shoji,Shinichi Nakanuma,Koichi Okamoto,Seisho Sakai,Isamu Makino,Keishi Nakamura,Hironori Hayashi,Masafumi Inokuchi,Hisatoshi Nakagawara,Tomoharu Miyashita,Hidehiro Tajima,Hiroyuki Takamura,Itasu Ninomiya,Hirohisa Kitagawa,Takashi Fujimura,Ryousuke Tajiri,Akishi Ooi,Tetsuo Ohta

Evaluation of serum HER2-ECD levels in patients with gastric cancer

2015

Background Determination of the human epidermal growth factor receptor 2 (HER2) status of gastric cancer patients is indispensable in clinical practice. However, the clinical value of serum HER2-extracellular domain (ECD) in gastric cancer has not yet been defined.

Keywords:

Clinical Practice
Cancer
Oncology
Human Epidermal Growth Factor Receptor 2
Diabetes mellitus
Medicine
Internal medicine
Hepatology
in patient
Surgical oncology
Abdominal surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations